4D Nucleome Network Wiki

User Tools

Site Tools

You are here: start » 4dn » nih_only_area » tcpa_egrant
4dn:nih_only_area:tcpa_egrant

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision 		Previous revision
4dn:nih_only_area:tcpa_egrant [2019/01/24 16:17]
rcalandrelli 		4dn:nih_only_area:tcpa_egrant [2025/04/22 16:21] (current)
Line 20: Line 20:
 In more recent developments within our 4 DN Working Group, we have decided to change the format a bit: In more recent developments within our 4 DN Working Group, we have decided to change the format a bit:
  
-  - In the Phase I, or first level of review (Equivalent to a Mail review), the assigned reviewers will each provide/​submit brief answers to questions in a critique template, and rate the applications by their level of enthusiasm as “High” “Medium” or “Low” for each of these applications. ​  ​NIH Officials (Staff with oversight of the 4 DN Program) will rank-order these applications based on the assessments,​ average levels of enthusiasm, and other Programmatic criteria, and prepare a subset of applications that will go forward to the second level of review.+  - In the Phase I, or first level of review (Equivalent to a Mail review), the assigned reviewers will each provide/​submit brief answers to questions in a critique template, and rate the applications by their level of enthusiasm as “High” “Medium” or “Low” for each of these applications. NIH Officials (Staff with oversight of the 4DN Program) will rank-order these applications based on the assessments,​ average levels of enthusiasm, and other Programmatic criteria, and prepare a subset of applications that will go forward to the second level of review.
   - The second level of review will constitute a half-day web-based/​teleconference editorial board-styled discussion to prioritize a subset of the above applications based on three criteria (To be determined),​ and using the same reviewers as in Phase I.   - The second level of review will constitute a half-day web-based/​teleconference editorial board-styled discussion to prioritize a subset of the above applications based on three criteria (To be determined),​ and using the same reviewers as in Phase I.
-  - It is also formally possible that we may not need ALL the Phase I reviewers to attend the “Second level of review”, based on the applications that are moved forward to that level. ​ Selection will naturally be based on that set of applications.+  - It is also formally possible that we may not need ALL the Phase I reviewers to attend the “Second level of review”, based on the applications that are moved forward to that level. Selection will naturally be based on that set of applications.
   - Reviewers will be paid a total honorarium of US$200.00   - Reviewers will be paid a total honorarium of US$200.00
   - We anticipate the Phase I or first level of review critiques to be submitted around the Middle of March (March 16-20th OR TBD)   - We anticipate the Phase I or first level of review critiques to be submitted around the Middle of March (March 16-20th OR TBD)
-  - We anticipate the second level of review (half-day web-based/​teleconference editorial board-styled discussion) to be April 3-7th OR TBD).  Writing assignments will be distributed and Panel members will be asked to write brief Resumes and Summaries of Discussion for each of the discussed applications.+  - We anticipate the second level of review (half-day web-based/​teleconference editorial board-styled discussion) to be April 3-7th OR TBD). Writing assignments will be distributed and Panel members will be asked to write brief Resumes and Summaries of Discussion for each of the discussed applications.
  
-  - The following review- related documents and capabilities will be/should be accessible at one convenient location at the OH-site that reviewers may be directed to.  Documents noted below will be sent to you in the next few days:+  - The following review- related documents and capabilities will be/should be accessible at one convenient location at the OH-site that reviewers may be directed to. Documents noted below will be sent to you in the next few days:
  
   * Applications (Should be available at OH site)   * Applications (Should be available at OH site)
Line 39: Line 39:
   * All review assessments and a roster of Reviewers will be released together at a time as determined by the NIH 4DN Working Group (TBD).   * All review assessments and a roster of Reviewers will be released together at a time as determined by the NIH 4DN Working Group (TBD).
  
-_________________________________________________________________________________________ +===== Review system ​=====
- +
-Review system+
  
 1. System design 1. System design
Line 65: Line 63:
 Credentials to login as a testing applicant: Credentials to login as a testing applicant:
  
-  ​Email: ucsd@mail.com+Email: ucsd@mail.com
  
-  ​Password: abcd1234+Password: abcd1234
  
 2.2. [[https://​docs.google.com/​viewer?​a=v&​pid=sites&​srcid=NGRudWNsZW9tZS5vcmd8NGQtbnVjbGVvbWUtd2lraXxneDo1YzlmOWU2OTAzNTVjNGE4|4DN eGrant system documentation.pptx]] shows an overview of the current status of the software. (11/​15/​2016) 2.2. [[https://​docs.google.com/​viewer?​a=v&​pid=sites&​srcid=NGRudWNsZW9tZS5vcmd8NGQtbnVjbGVvbWUtd2lraXxneDo1YzlmOWU2OTAzNTVjNGE4|4DN eGrant system documentation.pptx]] shows an overview of the current status of the software. (11/​15/​2016)
Line 85: Line 83:
 Personal Information Form Personal Information Form
  
--  First Name+- First Name
  
--  Last Name+- Last Name
  
--  Email+- Email
  
--  Address+- Address
  
--  City+- City
  
--  State+- State
  
--  Zip code+- Zip code
  
--  Country+- Country
  
 Project Information Form Project Information Form
  
--  Principal Investigators (it allows to insert 5 PIs, the first is mandatory while the others are optional)+- Principal Investigators (it allows to insert 5 PIs, the first is mandatory while the others are optional)
  
 Has this PI been funded by NIH 4DN program? Yes/No (for each PI) Has this PI been funded by NIH 4DN program? Yes/No (for each PI)
  
--  Institution Name+- Institution Name
  
--  Project Title+- Project Title
  
--  Are vertebrate animals used in this study? Yes/No+- Are vertebrate animals used in this study? Yes/No
  
--  Are there human subjects involved in this study? Yes/No+- Are there human subjects involved in this study? Yes/No
  
 - Additional notes (optional) - Additional notes (optional)
4dn/nih_only_area/tcpa_egrant.1548375420.txt.gz · Last modified: 2025/04/22 16:21 (external edit)

Page Tools